(Q41670282)

6 October 2017

1 reference

title

The effects of cetirizine on the function of inflammatory cells involved in the allergic response (English)

1 reference

6 October 2017

Walsh GM

1

1 reference

6 October 2017

publication date

1 November 1997

1 reference

Clinical & Experimental Allergy

6 October 2017

published in

1 reference

6 October 2017

volume

27 Suppl 2

1 reference

6 October 2017

page(s)

47-53; discussion 54-6

1 reference

Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1997.TB02583.X

In vitro effect of cetirizine on PGE2 release by rat peritoneal macrophages and human monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1997.TB02583.X

A new view of prostaglandin E regulation of the immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1997.TB02583.X

Allergic subjects express intercellular adhesion molecule--1 (ICAM-1 or CD54) on epithelial cells of conjunctiva after allergen challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1997.TB02583.X

Cetirizine exerts anti-inflammatory effects on human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1997.TB02583.X

Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1997.TB02583.X

Inhibitory effect of cetirizine on the bronchial eosinophil recruitment induced by allergen inhalation challenge in allergic patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1997.TB02583.X

Suppression by cetirizine of pleurisy triggered by antigen in actively sensitized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1997.TB02583.X

Inhibition of eosinophil chemotaxis by a new antiallergic compound (cetirizine).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1997.TB02583.X

The effects of cetirizine on the adhesion of human eosinophils and neutrophils to cultured human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1997.TB02583.X

Effects of Cetirizine on Human Eosinophil and Neutrophil Activation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1997.TB02583.X

Cetirizine inhibits the in vitro and ex vivo chemotactic response of T lymphocytes and monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1997.TB02583.X

Promotion of eosinophil survival by human bronchial epithelial cells and its modulation by steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1997.TB02583.X

Antihistamines and production of granulocyte-macrophage colony-stimulating factor and interleukin-8 by human bronchial epithelial cells in vitro: evaluation of the effects of loratadine and cetirizine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1997.TB02583.X

Blood and bronchoalveolar eosinophils in allergic subjects after segmental antigen challenge: surface phenotype, density heterogeneity, and prostanoid production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1997.TB02583.X

10.1111/J.1365-2222.1997.TB02583.X

21 January 2018

Identifiers

DOI

1 reference

6 October 2017

1 reference